What does Medisurg do?

Medisurg is a specialist medical practice in Lokeren. Private Limited, started on 27 February 2006, 1 establishment.

What is the address of Medisurg?

The registered office of Medisurg is located at H.-Geestmolenstraat 154, 9160 Lokeren.

Is Medisurg still active?

Yes. According to the CBE (15 November 2026) Medisurg is active, legal situation “Normale toestand”, started on 27 February 2006.

Is Medisurg registered on Peppol?

Yes, Medisurg is registered on the Peppol network with ID 0208:0879621536.

What is the enterprise number of Medisurg?

The enterprise number of Medisurg is BE0879621536.

When was Medisurg founded?

Medisurg was founded on 27 February 2006.

Who are the directors of Medisurg?

According to the 2025 annual accounts, the directors of Medisurg are: Hendrik Verroken.

Is Medisurg a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Medisurg make in 2025?

Medisurg posted a profit after taxes of € 128,953 in financial year 2025.

What is the revenue of Medisurg?

As a small company, Medisurg is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 199,968.

Medisurg (Private Limited) - Lokeren - BE0879621536

Dossier Medisurg, printed on 15 November 2026 from databakkes.be/en/0879621536/medisurg. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Medisurg from Lokeren, company number BE0879621536, closed financial year 2025 with a result of € 128,953 after tax. For that financial year Medisurg recorded a gross margin of € 199,968 and equity of € 1 million. Compared with financial year 2024, the result moved from € 123,365 to € 128,953. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.

What it is worth Growing

€ 1 million

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 128,953

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,053

▼ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 996,433.

People and assets in 2025

Vehicles and equipment

€ 4,421

▲ € 3,515 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 30,327

▼ 61% vs 2024

Loans from banks and other lenders, long and short.

Taxes

€ 30,443

▲ 122% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 155,134 Gross margin 2022: € 155,134 First fiscal year in the series	€ 148,347 Gross margin 2023: € 148,347 ▼ 4% vs 2022 (€ 155,134) Unfavourable step	€ 180,523 Gross margin 2024: € 180,523 ▲ 22% vs 2023 (€ 148,347) Favourable step	€ 199,968 Gross margin 2025: € 199,968 ▲ 11% vs 2024 (€ 180,523) Favourable step	▲ 11%
Profit after taxes	€ 86,260 Profit after taxes 2022: € 86,260 First fiscal year in the series	€ 85,683 Profit after taxes 2023: € 85,683 ▼ 1% vs 2022 (€ 86,260) Unfavourable step	€ 123,365 Profit after taxes 2024: € 123,365 ▲ 44% vs 2023 (€ 85,683) Favourable step	€ 128,953 Profit after taxes 2025: € 128,953 ▲ 5% vs 2024 (€ 123,365) Favourable step	▲ 5%
Equity	€ 670,833 Equity 2022: € 670,833 First fiscal year in the series	€ 756,516 Equity 2023: € 756,516 ▲ 13% vs 2022 (€ 670,833) Favourable step	€ 879,881 Equity 2024: € 879,881 ▲ 16% vs 2023 (€ 756,516) Favourable step	€ 1,008,833 Equity 2025: € 1,008,833 ▲ 15% vs 2024 (€ 879,881) Favourable step	▲ 15%
Total debts	€ 194,978 Total debts 2022: € 194,978 First fiscal year in the series	€ 154,133 Total debts 2023: € 154,133 ▼ 21% vs 2022 (€ 194,978) Favourable step	€ 98,047 Total debts 2024: € 98,047 ▼ 36% vs 2023 (€ 154,133) Favourable step	€ 65,801 Total debts 2025: € 65,801 ▼ 33% vs 2024 (€ 98,047) Favourable step	▼ 33%
Cash	€ 3,004 Cash 2022: € 3,004 First fiscal year in the series	€ 9,254 Cash 2023: € 9,254 ▲ 208% vs 2022 (€ 3,004) Favourable step	€ 21,955 Cash 2024: € 21,955 ▲ 137% vs 2023 (€ 9,254) Favourable step	€ 3,053 Cash 2025: € 3,053 ▼ 86% vs 2024 (€ 21,955) Unfavourable step	▼ 86%
Land & buildings	€ 531,818 Land & buildings 2022: € 531,818 First fiscal year in the series	€ 531,818 Land & buildings 2023: € 531,818 Unchanged (€ 531,818) Unchanged	€ 531,818 Land & buildings 2024: € 531,818 Unchanged (€ 531,818) Unchanged	€ 531,818 Land & buildings 2025: € 531,818 Unchanged (€ 531,818) Unchanged
Retained profit	€ 658,433 Retained profit 2022: € 658,433 First fiscal year in the series	€ 744,116 Retained profit 2023: € 744,116 ▲ 13% vs 2022 (€ 658,433) Favourable step	€ 867,481 Retained profit 2024: € 867,481 ▲ 17% vs 2023 (€ 744,116) Favourable step	€ 996,433 Retained profit 2025: € 996,433 ▲ 15% vs 2024 (€ 867,481) Favourable step	▲ 15%
Bank debt	€ 167,216 Bank debt 2022: € 167,216 First fiscal year in the series	€ 122,340 Bank debt 2023: € 122,340 ▼ 27% vs 2022 (€ 167,216) Favourable step	€ 78,010 Bank debt 2024: € 78,010 ▼ 36% vs 2023 (€ 122,340) Favourable step	€ 30,327 Bank debt 2025: € 30,327 ▼ 61% vs 2024 (€ 78,010) Favourable step	▼ 61%
Balance sheet total	€ 975,850 Balance sheet total 2022: € 975,850 First fiscal year in the series	€ 1,019,855 Balance sheet total 2023: € 1,019,855 ▲ 5% vs 2022 (€ 975,850) Unchanged	€ 1,086,302 Balance sheet total 2024: € 1,086,302 ▲ 7% vs 2023 (€ 1,019,855) Unchanged	€ 1,182,175 Balance sheet total 2025: € 1,182,175 ▲ 9% vs 2024 (€ 1,086,302) Unchanged	▲ 9%

By gross margin, Medisurg ranks 7th of 16 companies with main activity “Activiteiten van medisch specialisten” in Lokeren that publish figures (fiscal year 2025).

Key figures of Medisurg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Medisurg the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Medisurg?

What happened at Medisurg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 29, 2026 New annual accounts for financial year 2025: profit of € 128,953 (▲ 5% vs 2024). filed late Source: NBB ↗
Mar 9, 2006 Incorporation, published in the Gazette. Source: Staatsblad ↗
Feb 27, 2006 New establishment in Lokeren. KBO

In short

From € 86,260 profit in 2022 to € 128,953 profit in 2025.

Paid € 198,302 in corporate taxes since 2022.

Best year ever: 2025, with € 128,953 profit.

Original PDFs at the National Bank ↗

Management

Hendrik Verroken

Medisurg

Behind Medisurg is Hendrik Verroken.

Directors

According to the 2025 annual accounts

Hendrik Verroken

Director

Establishments

Establishment units

Physical locations of this company

Registered office

H.-Geestmolenstraat 154

9160 Lokeren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Lokeren

Same main activity (Activiteiten van medisch specialisten), 18 active companies in Lokeren, largest first.

DOKTER SERGOORIS

€ 996,361 gross margin · 2025

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE

€ 880,591 gross margin · 2025

FRIEDL VANHAVERBEKE

€ 554,706 gross margin · 2025

DR.ANNELIES GOEGEBUER

€ 453,715 gross margin · 2025

Dr. J. Goossens, Anesthesist

€ 426,409 gross margin · 2025

DOKTER GERAEDTS

€ 392,541 gross margin · 2026

All companies with this activity → Largest companies in Lokeren →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

9 March 2006 Source: Deed ↗

Hendrik Verroken(oprichter) 50%
Karlien Godelieve Josée Van Poucke(oprichter) 50%

Details

Company number

0879.621.536

VAT number

BE 0879.621.536

Registered office

H.-Geestmolenstraat 154, 9160 Lokeren

Names & denominations

Medisurg

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 February 2006

Peppol

Active · Active since 9 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Medisurg

Warning lights

Financials

Ask about Medisurg the way you would ask their accountant.

What happened to Medisurg?

Management

Directors

Establishments

Establishment units

Similar companies in Lokeren

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions